Psoriasis and Immobile

Summary:

Immobile is found among people with Psoriasis, especially for people who are female, 50-59 old.

The study analyzes which people have Immobile with Psoriasis. It is created by eHealthMe based on reports of 34 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,479 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Immobile?

Immobile (not moving) is found to be associated with 483 drugs and 582 conditions by eHealthMe. Check the latest studies of Immobile.

On Jul, 13, 2026

34 people who have Psoriasis and Immobile are studied.

Would you have Immobile when you have Psoriasis?

Gender of people who have Psoriasis and experienced Immobile *:

female: 58.82 %
male: 41.18 %

Age of people who have Psoriasis and experienced Immobile *:

Common co-existing conditions for these people *:

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 26.47%
Pain: 3 people, 8.82%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.88%
Depression: 2 people, 5.88%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.94%
Stress And Anxiety: 1 person, 2.94%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 2.94%
Joint Pain: 1 person, 2.94%
Insomnia (sleeplessness): 1 person, 2.94%
Heart Disease: 1 person, 2.94%

Common drugs taken by these people *:

Common symptoms for these people *:

Weakness: 5 people, 14.71%
Fall: 5 people, 14.71%
Joint Pain: 4 people, 11.76%
Pain In Extremity: 4 people, 11.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 8.82%
Rash Pustular (redness with pustules): 3 people, 8.82%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 8.82%
Joint Range Of Motion Decreased (disease of joint movement): 3 people, 8.82%
Dizziness: 3 people, 8.82%
Gait Disturbance: 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Immobile?

- Check whether Immobile is associated with a drug or a condition

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

Related studies:

Treatments, associated drugs and conditions:

Psoriasis (508,163 reports)
Immobile (5,336 reports)

All the drugs that are associated with Immobile:

Immobile (483 drugs)

All the conditions that are associated with Immobile:

Immobile (582 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Immobile and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.